» Articles » PMID: 23091449

Metastatic Renal Cell Carcinoma in a Supraclavicular Lymph Node with No Known Primary: a Case Report

Overview
Specialty Oncology
Date 2012 Oct 24
PMID 23091449
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Although metastasis is relatively frequent in cases of renal cell carcinoma (RCC), metastasis in the cervical or supraclavicular lymph node (LN) is relatively rare. Moreover, cases of metastatic RCC with a non-identifiable kidney mass are extremely rare. Here, the authors report a case of metastatic RCC in a supraclavicular LN without a primary kidney lesion. A 69-year-old man presented with a progressively enlarging right supraclavicular mass. Incisional biopsy of the affected supraclavicular LN was performed, and histological examination revealed metastatic RCC. However, no tumor was found in either kidney, despite various examinations. The patient was treated with radiotherapy followed by sunitinib. After three months on sunitinib, a follow-up computed tomography scan revealed that the supraclavicular LN had markedly decreased, and after 20 months, the disease had not progressed. This case suggests that, even when there is no primary kidney lesion, clinicians must consider the possibility of metastatic RCC when evaluating patients with clear cell carcinoma with an unknown primary site.

Citing Articles

The Relevance of the Virchow Node and Virchow Triad in Renal Cancer Diagnosis.

Dorobantu-Lungu L, Dinca V, Gegiu A, Spataru D, Toma A, Welt L Clin Pract. 2025; 15(1).

PMID: 39851801 PMC: 11763355. DOI: 10.3390/clinpract15010018.


Renal cell carcinoma metastasis without a primary: A case report.

Razi B, Cole-Clark D, Self D, Ghahan R, Latif E Urol Case Rep. 2024; 53:102658.

PMID: 38348274 PMC: 10859299. DOI: 10.1016/j.eucr.2024.102658.


Combined Immunotherapy and Tyrosine Kinase Inhibitor Treatment for Metastatic Renal Cell Carcinoma With Unknown Primary Origin: A Report of Two Cases and Literature Review.

Chen H, Yu L, Chang H, Huang W, Lin W, Chang C In Vivo. 2023; 37(4):1905-1913.

PMID: 37369518 PMC: 10347932. DOI: 10.21873/invivo.13285.


Central pancreatectomy in portal annular pancreas for metastatic renal cell carcinoma: a case report.

Yamaguchi H, Kimura Y, Nagayama M, Imamura M, Tanaka S, Yoshida M World J Surg Oncol. 2019; 17(1):76.

PMID: 31039791 PMC: 6492400. DOI: 10.1186/s12957-019-1622-8.


Metastatic renal cell carcinoma with undetectable renal mass presenting as lymphadenopathy.

Fayaz M, Al-Qaderi A, El-Sherify M CEN Case Rep. 2017; 6(1):36-38.

PMID: 28509124 PMC: 5438804. DOI: 10.1007/s13730-016-0239-9.


References
1.
Bhatia S, Ng S, Hodder S . Metastatic cutaneous head and neck renal cell carcinoma with no known primary: case report. Br J Oral Maxillofac Surg. 2009; 48(3):214-5. DOI: 10.1016/j.bjoms.2009.11.012. View

2.
Rasco D, Assikis V, Marshall F . Integrating metastasectomy in the management of advanced urological malignancies-where are we in 2005?. J Urol. 2006; 176(5):1921-6. DOI: 10.1016/j.juro.2006.07.003. View

3.
Golimbu M, Joshi P, Sperber A, Tessler A, AL-ASKARI S, Morales P . Renal cell carcinoma: survival and prognostic factors. Urology. 1986; 27(4):291-301. DOI: 10.1016/0090-4295(86)90300-6. View

4.
Maldazys J, DeKernion J . Prognostic factors in metastatic renal carcinoma. J Urol. 1986; 136(2):376-9. DOI: 10.1016/s0022-5347(17)44873-7. View

5.
Pritchyk K, Schiff B, Newkirk K, Krowiak E, Deeb Z . Metastatic renal cell carcinoma to the head and neck. Laryngoscope. 2002; 112(9):1598-602. DOI: 10.1097/00005537-200209000-00012. View